Nav: Home

Samumed selected for 7 presentations in 5 therapeutic areas at ACR 2016

November 01, 2016

San Diego, CA--November 1, 2016 - Samumed, a leader in tissue regeneration, today announced it has been selected to feature seven presentations in five different therapeutic areas at the 2016 American College of Rheumatology (ACR) Annual Meeting from November 11-16 in Washington, D.C.

The ACR Annual Meeting is the premier educational event for physicians, health professionals and scientists who treat those with or at risk for arthritis, rheumatic and musculoskeletal diseases. Samumed's presentations will focus on the application of the company's novel, small-molecule Wnt pathway inhibitor compounds to treat the underlying pathology leading to the symptoms rather than the symptoms alone of the following diseases: Chronic Tendinopathy, Degenerative Disc Disease, Scleroderma, Osteoarthritis and Psoriasis.

"Samumed's unique understanding of the cell process and how to modulate it enables us to develop drugs that actually recover and restore the health of diseased tissues as opposed to simply providing symptom relief," said Yusuf Yazici, M.D., Chief Medical Officer of Samumed. "We are excited to return to the ACR Annual Meeting with seven presentations that highlight the progress we've made in five disease areas with two of our small-molecule compounds, SM04755 and SM04690."

Samumed's technology platform is based on the company's ability to modulate a cell process known as the Wnt pathway--which regulates the self-renewal and differentiation of adult stem cells and has been implicated in hundreds of diseases, primarily in oncology and various degenerative conditions. The company currently has seven clinical-stage programs in development.

In addition to progress in rheumatology, Samumed has also made progress recently in other areas. Researchers recently completed a successful Phase I trial in Pulmonary Fibrosis and will be launching the next phase trial this year. The company expects to report results from an Androgenic Alopecia trial at a medical conference in spring 2017.

Samumed CEO Osman Kibar recently spoke about the full breadth of the company's research efforts in a presentation to the Royal Society of Medicine in London, which can be viewed at https://videos.rsm.ac.uk/video/regenerative-medicine-platform-initiative.

Abstracts about Samumed's seven ACR presentations are available online at the ACR Meeting Abstract webpage.

Below is the full list of the Samumed presentations at ACR and information about the diseases:

PRESENTATION INFORMATION

Title: Discovery of a Small Molecule Inhibitor of the Wnt Pathway (SM04755) As a Potential Topical Treatment for Chronic Tendinopathy
Date: November 14, 2016
Abstract number: 1104

Title: Discovery of a Small Molecule Inhibitor of the Wnt Pathway (SM04755) As a Potential Topical Treatment for Scleroderma
Date: November 14, 2016
Abstract number: 1856

Title: Discovery of a Small Molecule Inhibitor of the Wnt Pathway (SM04690) As a Potential Treatment for Degenerative Disc Disease
Date: November 15, 2016
Abstract number: 2120

Title: A Small Molecule, SM04690, Has Inhibitory Effects on the Wnt Pathway and Inflammation in Vitro, with Potential Implications for the Treatment of Osteoarthritis
Date: November 15, 2016
Abstract number: 2143

Title: Radiographic Outcomes from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee
Date: November 15, 2016
Abstract number: 2350

Title: Analysis of Pain and Function Components in Omeract-Oarsi Strict Responders from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee
Date: November 15, 2016
Abstract number: 2368

Title: Discovery of a Small Molecule Inhibitor of the Wnt Pathway (SM04755) As a Potential Topical Treatment for Psoriasis
Date: November 15, 2016
Abstract number: 2704
-end-
DISEASE INFORMATION

ABOUT CHRONIC TENDINOPATHY


Chronic Tendinopathy is an inflammatory and degenerative condition caused by injuries or overuse.

ABOUT SCLERODERMA

Scleroderma is an autoimmune fibrotic disease, which presents skin manifestations among others.

ABOUT DEGENERATIVE DISC DISEASE

Degenerative Disc Disease (DDD), one of the main causes of low back pain, is characterized by degeneration of intervertebral disc, nucleus pulposus and cartilage matrix, resulting in decreased disc height and function.

ABOUT OSTEOARTHRITIS

Osteoarthritis (OA) involves thinning cartilage and increased subchondral bone. Amongst many cellular processes, inflammation has been associated with OA.

ABOUT PSORIASIS

Psoriasis is an autoimmune disease of the skin, characterized by inflammation and fibrosis, producing patches of red, itchy and scaly skin.

ABOUT SAMUMED, LLC

Based in San Diego, CA, Samumed is a pharmaceutical platform company focused on advancing regenerative medicine and oncology applications through research and innovation. Samumed has discovered new targets and biological processes in the Wnt pathway, allowing the team to develop small molecule drugs that potentially address numerous degenerative conditions as well as many forms of cancer.

Samumed, LLC

Related Osteoarthritis Articles:

Cross-species links identified for osteoarthritis
New research from the University of Liverpool, published today in the journal NPJ Systems Biology and Applications, has identified 'cell messages' that could help identify the early stages of osteoarthritis.
Findings do not support steroid injections for knee osteoarthritis
Among patients with knee osteoarthritis, an injection of a corticosteroid every three months over two years resulted in significantly greater cartilage volume loss and no significant difference in knee pain compared to patients who received a placebo injection, according to a study published by JAMA.
Osteoarthritis could be prevented with good diet and exercise
Osteoarthritis can potentially be prevented with a good diet and regular exercise, a new expert review published in the Nature Reviews Rheumatology reports.
Hand osteoarthritis is a common condition
A new study estimates that the lifetime risk of symptomatic hand osteoarthritis is 40 percent, and nearly one in two women and one in four men will develop the condition, which affects hand strength and function and causes disability in activities of daily living.
Noisy knees may be an early sign of knee osteoarthritis
A new study using data from the Osteoarthritis Initiative, a multi-center observational study of nearly 3500 participants, indicates that people who hear grating, cracking, or popping sounds in or around their knee joint may be at increased risk of developing knee osteoarthritis.
Improvements in ACL surgery may help prevent knee osteoarthritis
Injury to the anterior cruciate ligament (ACL) in the knee frequently leads to early-onset osteoarthritis, a painful condition that can occur even if the patient has undergone ACL reconstruction to prevent its onset.
Clinical trial for new innovative osteoarthritis drug
The University of Liverpool, in partnership with AKL Research and Development Ltd, is to lead on a clinical trial to test a potential new drug treatment for osteoarthritis.
Blood test for early osteoarthritis diagnosis unveiled
Patients could soon be diagnosed with early-stage arthritis several years before the onset of physical and irreversible symptoms, thanks to a new test developed by researchers at the University of Warwick.
Osteoarthritis just as severe as rheumatoid arthritis
Rheumatologists more likely to underestimate clinical status of their OA patients than their RA patients
Tissue fluid flow can reveal onset of osteoarthritis
Reflecting the overall structural alterations in the tissue, changes in the flow of interstitial fluid in articular cartilage could be an indicator revealing the onset of osteoarthritis, according to a new study from the University of Eastern Finland.

Related Osteoarthritis Reading:

HIP Osteoarthritis CAN be Cured: Treating OA with Physical Therapy
by Susan Westlake (Author)

Osteoarthritis: Preventing and Healing Without Drugs
by Peter Bales (Author)

Treat Your Own Hand and Thumb Osteoarthritis
by Jim Johnson (Author)

Arthritis in knee, osteoarthritis in knee. Knee arthritis types, knee exercises and stretches, treatments, home remedies, knee replacements and knee braces all covered.
by Robert Rymore (Author)

The Arthritis Cure: The Medical Miracle That Can Halt, Reverse, And May Even Cure Osteoarthritis
by Jason Theodosakis (Author), Sheila Buff (Author), Barry Fox (Author)

Arthritis: What Exercises Work: Breakthrough Relief for the Rest of Your Life, Even After Drugs & Surgery Have Failed
by Dava Sobel (Author), Arthur C. Klein (Author)

Quantitative Medicine: Using Targeted Exercise and Diet to Reverse Aging and Chronic Disease
by Golden Lotus Publishing

Arthritis: Fight it with the Blood Type Diet: The Individualized Plan for Defeating the Pain of Osteoarthritis, Rheumatoid Art hritis, Fibromyalgia, ... Conditions (Eat Right 4 Your Type)
by Dr. Peter J. D'Adamo (Author), Catherine Whitney (Author)

Water Exercises for Osteoarthritis: The Effective Way to Reduce Pain and Stiffness, While Increasing Endurance and Strength
by Ann A. Rosenstein (Author)

Strong Women and Men Beat Arthritis: Cutting-Edge Strategies for the Relief of Rheumatoid and Osteoarthritis
by Miriam E. Nelson Ph.D (Author), Kristin Baker (Author), Lawrence Lindner M.A. (Author), Ronenn Roubenoff (Author)

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Dying Well
Is there a way to talk about death candidly, without fear ... and even with humor? How can we best prepare for it with those we love? This hour, TED speakers explore the beauty of life ... and death. Guests include lawyer Jason Rosenthal, humorist Emily Levine, banker and travel blogger Michelle Knox, mortician Caitlin Doughty, and entrepreneur Lux Narayan.
Now Playing: Science for the People

#492 Flint Water Crisis
This week we dig into the Flint water crisis: what happened, how it got so bad, what turned the tide, what's still left to do, and the mix of science, politics, and activism that are still needed to finish pulling Flint out of the crisis. We spend the hour with Dr Mona Hanna-Attisha, a physician, scientist, activist, the founder and director of the Pediatric Public Health Initiative, and author of the book "What the Eyes Don't See: A Story of Crisis, Resistance, and Hope in an American City".